Nantahala Capital Management »

Instil Bio shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Instil Bio (TIL) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Instil Bio

Tip: Access up to 7 years of quarterly data

All positions including Instil Bio held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Instil Bio by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.3M 127k 10.29
2024-03-31 $1.4M 127k 10.80
2023-12-31 $970k 127k 7.62

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Eli Lilly & Co. Put Option (LLY)
Eli Lilly & Co. Put Option (LLY)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Spdr Ser Tr S&p Biotech (XBI)
Spdr Ser Tr S&p Biotech (XBI)
Peloton Interactive Cl A Com (PTON)
Peloton Interactive Cl A Com (PTON)
Grand Canyon Education Put Option (LOPE)
Grand Canyon Education Put Option (LOPE)
Imax Corp Cad (IMAX)

View all positions for Nantahala Capital Management

Top funds holding Instil Bio

CPMG
BML Capital Management
Cable Car Capital
Vanguard Group
Nantahala Capital Management
Renaissance Technologies
BlackRock
Marshall Wace
Geode Capital Management
Millennium Management
Two Sigma Advisers
Two Sigma Investments
State Street Corporation
Acadian Asset Management
Morgan Stanley

View all funds holding Instil Bio